B.Pharm

Olefia Biopharma Limited is one of most dynamic organizations, involved in manufacturing pharmaceutical formulations marketing its products in India as well as worldwide. Olefia has been pursuing its primary mission to provide quality healthcare to ailing millions across the globe at an affordable cost. “Where there is will there is way” is the ground principle for us and based on this principle. Olefia is working today as diverse company of the future.

Post : PMT & CRM

Company profile - 25 years old company with more than 180 products range and 125 distribution sites PAN India.

Post : MANAGER

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Specialist-Quality Operations

MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities / threats which will impact 70% to 80% of worldwide companies’ revenues. The company currently caters to 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their pain points around revenue decisions. Our 850 fulltime SMEs and analysts at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities and important customers, write "Attack, Avoid and Defend" strategies, objectify sources of incremental revenues for both the company and its competitors. MarketsandMarkets is now coming up with 1,500 Micro Quadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in emerging segments experiencing high growth.

Post : Research Associate

Established in the year 1978 as an exclusive facility for Small Volume Parenterals (SVPs), Gland Pharma has developed into a progressive and quality conscious organization serving the pharmaceutical needs of diverse markets across the globe.
The Company has world-class & world-scale facilities for injectables set up in collaboration with Vetter Group, Germany. The collaboration with Vetter provides Gland Pharma a technological edge in injectables and specifically in Pre Filled Syringes.

Tata Trusts is amongst India's oldest, non-sectarian philanthropic organisations. The Trusts own two-third of the stock holding of Tata Sons, the apex company of the Tata group of companies. The wealth that accrues from this asset supports an assortment of causes, institutions and individuals in a wide variety of areas. In this manner, the profits that the Tata companies earn go back many times over to the communities they operate in. These funds have been deployed towards a whole range of community development programmes across the country, for over a 100 years now.

Post : Education grants

Birla Institute of Technology & Science (BITS), Pilani a leading Institute of Higher Education and a deemed University under section 3 of the UGC act offers degree programmes in Engineering, Sciences, Technology, Pharmacy, Management and Humanities. This web site describes the admission modalities for the on-campus degree progarmmes  offered at Pilani campus, Goa Campus and Hyderabad Campus.

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Post: Manager Regulatory Affairs

Merck Limited (formerly E. Merck Limited) was set up in India as the first Merck subsidiary in Asia in 1967.  The Company operates both its Pharmaceuticals and Chemicals businesses in the country.
Merck was also the first Merck Group Company to go public in the year 1981.  The Merck Group now holds 51% of the share capital in Merck Limited, while the remaining 49% is traded on the Bombay Stock Exchange Ltd. and National Stock Exchange of India Ltd.  Merck Specialities Pvt. Ltd., the wholly owned Indian subsidiary of Merck KGaA, was incorporated in 2005.

Post : Manager - Regulatory Affairs